Related to LBL to Supply Proliant BSA to Small-Scale Customers

• China Biologic Allies with Chinese Institute to Improve Production of Plasma-Based Products
  
• SAFC Completes $12M Plant Expansion
  
• Formatech to Donate Services to Formulate and Fill a GeoVax HIV Vaccine
  
• Novavax Taps Xcellerex to Bolster Flu Vaccine Production
  
• Alnara Selects Lonza for Commercial Manufacture of Pancreatic Insufficiency Therapy
  
• Lonza Takes Equity Stake in Ciliate-Expression System Company
  
• ArmaGen Chooses PacificGMP to Manufacture Fusion Protein for Phase I Trial in Stroke and Parkinson’s
  
• ProMetic to Provide Halozyme with Synthetic Ligand Affinity Adsorbent
  
• Talecris Pours $268.7M into Production Plant in North Carolina
  
• Novartis Inaugurates $1B U.S. Cell Culture Flu Vaccine Facility
  
• BioLife to Produce Custom Biopreservation Media for Centocor
  
• Cancer Research UK to Conduct Phase I Trial with Merck KGaA’s B-Cell Lymphoma Candidate
  
• Scientists Create Insect-Cell Approach to Produce Swine Flu Vaccines
  
• ProMetic and Abraxis Team Up to Develop New Applications of Prion-Capture Platform
  
• BioMimetic Strengthens Arrangement with Novartis for Exclusive Supply of Recombinant Human Platelet-Derived Growth Factor
  
• Lonza Launches Cells on Demand Services for Cell Culture and Transfection
  
• Formatech to Fill and Finish One Lot of KAI Pharmaceuticals’ SHPT Drug at No Charge
  
• Lonza to Manufacture Micromet’s Blinatumomab BiTE Antibody
  
• Therapure Biopharma to Perform Fill/Finish of YM Biosciences’ Nimotuzumab
  
• Formatech to Fill and Finish One Lot of ViroMed’s Preclinical Cancer Vaccine at No Charge